Ausgabe 5/2012
Inhalt (15 Artikel)
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
Kyriaki Ioannou, Pinelopi Samara, Evangelia Livaniou, Evelyna Derhovanessian, Ourania E. Tsitsilonis
Long-term proliferation of functional human NK cells, with conversion of CD56dim NK cells to a CD56bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
Alexander C. Dowell, Kimberley A. Oldham, Rupesh I. Bhatt, Steven P. Lee, Peter F. Searle
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Christina S. Chu, Jean Boyer, Daniel S. Schullery, Phyllis A. Gimotty, Victoria Gamerman, James Bender, Bruce L. Levine, George Coukos, Stephen C. Rubin, Mark A. Morgan, Robert H. Vonderheide, Carl H. June
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice
Melisa J. Hamilton, Judit P. Banáth, Vivian Lam, Nancy E. LePard, Gerald Krystal, Kevin L. Bennewith
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma
Jun Zhou, Noah K. Yuen, Qian Zhan, Elsa F. Velazquez, George F. Murphy, Anita Giobbie-Hurder, F. Stephen Hodi
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells
Nanae Harashima, Tohko Inao, Ryu Imamura, Shinji Okano, Takashi Suda, Mamoru Harada
A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo
Jinpiao Lin, Rongfen Huo, Li Wang, Zhou Zhou, Yue Sun, Baihua Shen, Rongfang Wang, Ningli Li
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy
Laurence M. Wood, Zhen-Kun Pan, Matthew M. Seavey, Geetha Muthukumaran, Yvonne Paterson
Scutellaria extract and wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-β1 activity
Sagar Dandawate, Linford Williams, Nirmal Joshee, Agnes M. Rimando, Sandeep Mittal, Archana Thakur, Lawrence G. Lum, Prahlad Parajuli
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
Adam E. Snook, Michael S. Magee, Glen P. Marszalowicz, Stephanie Schulz, Scott A. Waldman
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy
Gustav J. Ullenhag, Arian M. Sadeghi, Björn Carlsson, Håkan Ahlström, Firas Mosavi, Gunnar Wagenius, Thomas H. Tötterman
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab
Vafa Shahabi, Gena Whitney, Omid Hamid, Henrik Schmidt, Scott D. Chasalow, Suresh Alaparthy, Jeffrey R. Jackson
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011
Natalia Aptsiauri, Teresa Cabrera, Angel Garcia-Lora, Federico Garrido
Comment on “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” by Gustav J. Ullenhag et al.
Inge Marie Svane
Response to the letter to the editors from Inge Marie Svane on our manuscript “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy”
Gunnar Wagenius, Gustav J. Ullenhag, Thomas H. Tötterman